NCT02086682|CompletedResults
Loading search results
Sponsor study identifier
observational
338
1 country
1
Study Start
January 2014
Actual (reported)Primary Completion
August 2015
Actual (reported)Study Completion
August 2015
Actual (reported)The introduction of unfractionated heparin (UFH), which prevents clotting of the extracorporal circuit, was one of the key advances that led to the rapid development and expansion of hemodialysis services. However, anticoagulation during hemodialysis of the patient at high risk for bleeding remains a frequently encountered problem in both inpatient and outpatient dialysis practice. Streamline bloodlines are designed to eliminate blood-air contact. This is thought to help reduce heparin use and decrease clotting rates. The goal of this study was to prospectively examine impact of the Streamline airless blood tubing set, in an inpatient setting, on dialysis circuit clotting rates, anticoagulation use, and dialysis efficiency.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 2015
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 2014
Actual (reported)March 10, 2014
Actual (reported)March 13, 2014
Actual (reported)August 2015
Actual (reported)August 2015
Actual (reported)July 15, 2019
Actual (reported)Clotting of Extracorporeal Dialysis Circuit
Each dialysis session was prospectively observed for Clotting of Extracorporeal Dialysis Circuit. Events were defined as interruption of hemodialysis session, loss of the hemodialysis circuit, or inability to return blood to the patient upon rinse back.
During the dialysis session, approximately 211 minutes
The group included adult hospitalized patients requiring hemodialysis at the inpatient dialysis unit. This was an observational study, with no interventions.
The group included adult hospitalized patients requiring hemodialysis at the intensive care unit. This was an observational study, with no interventions.
The group included adult hospitalized patients requiring hemodialysis at the inpatient dialysis unit or the ICU during the recruitment period.
Mayo Clinic Hospital, Saint Marys Campus
Rochester, Minnesota, 55902, United States
Safadi S, Albright RC Jr, Dillon JJ, Williams AW, Alahdab F, Brown JK, Severson AL, Kremers WK, Ryan MA, Hogan MC. Prospective Study of Routine Heparin Avoidance Hemodialysis in a Tertiary Acute Care Inpatient Practice. Kidney Int Rep. 2017 Mar 16;2(4):695-704. doi: 10.1016/j.ekir.2017.03.003. eCollection 2017 Jul.
Marie C. Hogan, M.D., Ph.D.
Mayo Clinic
338 participants (actual enrollment reported by the registry).
First Submitted
March 10, 2014
First Posted
March 13, 2014
Study Start
January 2014
Actual (reported)Functional Electrical Stimulation (FES) Exercise Training in Hemodialysis Patients
Contact the study team to confirm eligibility.
Primary Completion
August 2015
Actual (reported)Study Completion
August 2015
Actual (reported)Last Updated
July 15, 2019
Results First Posted
July 15, 2019
Record last verified: 2019-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: